Study of Mindfulness-Based Cognitive Therapy (MBCT)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sean Barnes, Binghamton University
ClinicalTrials.gov Identifier:
NCT00943033
First received: July 13, 2009
Last updated: September 19, 2012
Last verified: September 2012
  Purpose

Research aimed at assessing changes in depressogenic thinking and the ability to disengage from depressogenic thinking following Mindfulness-Based Cognitive Therapy


Condition Intervention
Major Depressive Disorder
Behavioral: Mindfulness-Based Cognitive Therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Toward Identifying the Mechanisms of Action in Mindfulness-Based Cognitive Therapy

Resource links provided by NLM:


Further study details as provided by Binghamton University:

Primary Outcome Measures:
  • Sustained Attention to Response Task [ Time Frame: zero to four weeks pre-treatment and zero to three weeks post-treatment ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Five Facet Mindfulness Questionnaire [ Time Frame: zero to four weeks pre-treatment and zero to three weeks post-treatment ] [ Designated as safety issue: No ]

Enrollment: 48
Study Start Date: August 2009
Study Completion Date: July 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Mindfulness-Based Cognitive Therapy plus treatment as usual Behavioral: Mindfulness-Based Cognitive Therapy
Mindfulness-Based Cognitive Therapy for the prevention of depressive relapse/recurrence
No Intervention: MBCT Waitlist plus Treatment as Usual

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • History of two or more Major Depressive Episodes or history of a Major Depressive Episode lasting at least one year
  • Can speak, read, and understand English

Exclusion Criteria:

  • Meet Criteria for Current Major Depressive Episode or are in partial remission
  • BDI-II score above 19
  • Abuse alcohol or drugs
  • Current Dysthymic Disorder
  • History of: psychosis when not depressed or intoxicated, Mania, Hypomania, Obsessive Compulsive Disorder, Posttraumatic Stress Disorder, Anorexia Nervosa, Bulimia Nervosa
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00943033

Sponsors and Collaborators
Binghamton University
Investigators
Principal Investigator: Sean M. Barnes, MS Binghamton University SUNY
  More Information

No publications provided

Responsible Party: Sean Barnes, PhD, Binghamton University
ClinicalTrials.gov Identifier: NCT00943033     History of Changes
Other Study ID Numbers: MLI-FJVRF-08-SMB
Study First Received: July 13, 2009
Last Updated: September 19, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Binghamton University:
MBCT
Mindfulness-Based Cognitive Therapy
Mindfulness
Meditation
Relapse Prevention
Recurrent Depression
Depression
Major Depressive Disorder

Additional relevant MeSH terms:
Depressive Disorder
Depression
Depressive Disorder, Major
Mood Disorders
Mental Disorders
Behavioral Symptoms

ClinicalTrials.gov processed this record on July 31, 2014